Evidence map›Paper›PMID 24966720›Full record

ReviewEuropean journal of dentistry2013

Possible recurrence of keratocyst in nevoid basal cell carcinoma syndrome: A review of literature.

Bassel Tarakji, Kusai Baroudi, Salah Hanouneh, Saleh Naser Azzeghaiby, Mohammad Zakaria Nassani

Open access · hybridAbstract readReview
In one paragraph

Review in European journal of dentistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Appearance and recurrence of odontogenic keratocysts.Clinical and experimental dental research · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Bassel TarakjiDepartment of Oral Medicine and Diagnostic Sciences, Al-Farabi Dental College, Riyadh, Saudi Arabia.
Kusai BaroudiDepartment of Restorative Dental Sceinces, Al-Farabi Dental College, Riyadh, Saudi Arabia.
Salah HanounehDepartment of Restorative Dental Sceinces, Al-Farabi Dental College, Riyadh, Saudi Arabia.
Saleh Naser AzzeghaibyDepartment of Restorative Dental Sceinces, Al-Farabi Dental College, Riyadh, Saudi Arabia.
Mohammad Zakaria NassaniDepartment of Restorative Dental Sceinces, Al-Farabi Dental College, Riyadh, Saudi Arabia.
Al-Farabi College · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review will highlight some current areas of difficulty or controversy in diagnosis and treatment of nevoid basal cell carcinoma syndrome (NBCCS). The odontogenic keratocyst (OKC) has significant growth capacity and recurrence potential and is occasionally indicative of the NBCCS. The objective of this study is to clarify the causes of the recurrence of OKC in NBCCS. A literature search was conducted using Medline, accessed via the National Library of Medicine PubMed interface, searching for articles relating to the cause of recurrence of keratocyst in NBCCS written in English. This study has described the previous and the current outcomes of the treatment of OKC (recurrent cause). A protocol was then agreed to search for the possible causes of keratocyst recurrence in NBCCS. The general treatment of other manifestation of NBCCS has excluded from this study. Studies describing cohort, case series and miscellaneous clinical reports were retrieved and evaluated from 2010 to 2012.

Indexed as

Basal cell carcinomaskeratocystnevoid basal cell carcinoma syndrome

Identifiers

PMID24966720
PMCPMC4054071
OpenAlexW2073330447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.